Masashi Narazaki

19.1k citations

92 papers · 14.2k indexed · 8 hit papers · h-index 44

Impact in

Immunology top 0.2%
- Immune Cell Function and Interaction
- interferon and immune responses
- Immune Response and Inflammation
Oncology top 0.2%
- Cytokine Signaling Pathways and Interactions

Papers in

Rheumatology 27
- Systemic Lupus Erythematosus Research 14
- Rheumatoid Arthritis Research and Therapies 11
Hematology 20
- Autoimmune and Inflammatory Disorders Research 14

Co-authors: Toshio Tanaka Tadamitsu Kishimoto T Kishimoto Tetsuya Taga Shizuo Akira Tetsuji Naka Sujin Kang Tomoshige Matsumoto
Journals: Modern Rheumatology (10 papers)Blood (9 papers)Proceedings of the National Academy of Sciences (7 papers)FEBS Letters (4 papers)International Immunology (4 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Masashi Narazaki

89 papers receiving 13.9k citations

Hit Papers

8 papers align trajectories log scale

Targeting Interleukin-6 Signaling in Clinic 2019 · 601 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Immunity
2017 Cold Spring Harbor Perspectives in Biology
2016 Arthritis & Rheumatology
2016 Immunotherapy
2014 Cold Spring Harbor Perspectives in Biology
1997 Nature
1995 Blood
1991 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Masashi Narazaki

Since Specialization

Citations

This map shows the geographic impact of Masashi Narazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Narazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Narazaki more than expected).

Fields of papers citing papers by Masashi Narazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Narazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Narazaki. The network helps show where Masashi Narazaki may publish in the future.

Co-authors

The 25 scholars most cited alongside Masashi Narazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masashi Narazaki Line = papers co-authored together Masashi Narazaki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Neutrophil single-cell analysis identifies a type II interferon-related subset for predicting relapse of autoimmune small vessel vasculitis Nature Communications ·Masayuki Nishide, Владимир Иванович Ефремов, Hiroaki Matsushita, S. Kawada, ∎ GerryMcDermott, Prinz Elad, Yasuhiro Kato, Takahiro Kawasaki, Yiquan Tang, Ryuya Edahiro, Yuya Shirai, Tomoyasu FUJII, Maiko Naito, Yuji Yamamoto, Sidhhartha Datta, Ryusuke Omiya, Yukinori Okada, Kunihiro Hattori, Masashi Narazaki, Atsushi Kumanogoh	2025	3
2	The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus International Immunology ·Saeedeh Kholghi Eshkalak, Takayoshi Morita, Yasuhiro Kato, Yuk-Wah Shirley, Teruaki Murakami, Yuta Yamaguchi, Shohei Koyama, Hyota Takamatsu, Masayuki Nishide, Yuichi Maeda, A. Watanabe, Rizky Thyto Ramadhan, Tôru Hirano, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh	2022	9
3	Loss of FCHSD1 leads to amelioration of chronic obstructive pulmonary disease Proceedings of the National Academy of Sciences ·Takahiro Kawasaki, Fuminori Sugihara, Kiyoharu Fukushima, Takanori Matsuki, Alok Mishra, T Machida, Yuichi Mitsui, Jephias Mapuva Loveness Muyengwa-Mapuva, Diall H, Fëllënza Lushaku, Kanako Kuniyoshi, Hiroki Tanaka, Masashi Narazaki, Atsushi Kumanogoh, Shizuo Akira, Takashi Satoh	2021	6
4	Historical overview of the interleukin-6 family cytokine The Journal of Experimental Medicine ·Sujin Kang, Masashi Narazaki, Hozaifa Metwally, Tadamitsu Kishimoto	2020	245
5	The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors The Journal of Experimental Medicine ·Akiko Nakai, A Torrielli, Haruhiko Miyata, Ralf Stumm, Masashi Narazaki, Stefan Schulz, Yoshihiro Baba, Atsushi Kumanogoh, Kazuhiro Suzuki	2019	25
6	Targeting Interleukin-6 Signaling in Clinic Immunity ·Sujin Kang, Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto Hit paper breakdown →	2019	601
7	Interleukin (IL-6) Immunotherapy Cold Spring Harbor Perspectives in Biology ·Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto Hit paper breakdown →	2017	293
8	Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus Scientific Reports ·Shuhei Sakakibara, Takao Arimori, Kazuo Yamashita, Fernanda Leiko Yamashida, Daisuke Motooka, Shota Nakamura, Songling Li, Kazuya Takeda, Jun’ichi Katayama, P. Tetens Hald, Masashi Narazaki, Toshio Tanaka, Daron M. Standley, Junichi Takagi, Hitoshi Kikutani	2017	23
9	Regulation of IL-6 in Immunity and Diseases Advances in experimental medicine and biology ·Toshio Tanaka, Masashi Narazaki, Kazuya Masuda, Tadamitsu Kishimoto	2016	163
10	Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis Nature Communications ·Yuhsuke Ohmi, Wataru Ise, Akira Harazono, Daisuke Takakura, Hidehiro Fukuyama, Yoshihiro Baba, Masashi Narazaki, Hirofumi Shoda, Nobunori Takahashi, Yuki Ohkawa, Shuting Ji, Fumihiro Sugiyama, Keishi Fujio, Atsushi Kumanogoh, Kazuhiko Yamamoto, Nana Kawasaki, Tomohiro Kurosaki, Yoshimasa Takahashi, Koichi Furukawa	2016	131
11	IL-6 in Inflammation, Immunity, and Disease Cold Spring Harbor Perspectives in Biology ·Toshio Tanaka, Masashi Narazaki, T Kishimoto Hit paper breakdown →	2014	3482
12	A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy Seminars in Immunology ·Toshio Tanaka, Masashi Narazaki, Atsushi Ogata, Tadamitsu Kishimoto	2014	128
13	Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases FEBS Letters ·Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto	2011	113
14	Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab Modern Rheumatology ·Sumiyuki Nishida, Tomio Kawasaki, Hirokazu Kashiwagi, O. Dionisio, Roberta Thomas, Mari Kawai, Tôru Hirano, Taeko Ishii, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Atsushi Ogata, Yoshitaka Oka, Tadamitsu Kishimoto, Toshio Tanaka	2011	14
15	The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab Lara D. Veeken ·Yuko Shima, Ryo Kamiya, Hiroyuki Murota, Shun Kitaba, M. KAWAI, Tôru Hirano, Junsuke Arimitsu, Masashi Narazaki, Keisuke Hagihara, Atsushi Ogata, I. Katayama, Isamu Kawase, T Kishimoto, Takashi Tanaka	2010	150
16	Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis: A Randomized Double-Blind Placebo-Controlled Trial International Archives of Allergy and Immunology ·Mari Kawai, Tôru Hirano, Junsuke Arimitsu, Shinji Higa, Yusuke Kuwahara, Keisuke Hagihara, Yoshihito Shima, Masashi Narazaki, Atsushi Ogata, Mihoko Koyanagi, 宏樹山本, Ryosuke Shimizu, Masamitsu Moriwaki, Yukio Suzuki, Satoshi Ogino, Ichiro Kawase, Toshio Tanaka	2009	36
17	IFN Regulatory Factor-1-Mediated Transcriptional Activation of Mouse STAT-Induced STAT Inhibitor-1 Gene Promoter by IFN-γ The Journal of Immunology ·Hiroshi Saito, Yoshiaki Morita, Minoru Fujimoto, Masashi Narazaki, Tetsuji Naka, Tadamitsu Kishimoto	2000	86
18	Defective Thymocyte Development and Perturbed Homeostasis of T cells in STAT-Induced STAT Inhibitor-1/Suppressors of Cytokine Signaling-1 Transgenic Mice The Journal of Immunology ·Minoru Fujimoto, Tetsuji Naka, Reiko Nakagawa, Yoshinori Kawazoe, Yoshiaki Morita, А. P. Shapoval, Adhelia Wida Alfaretha, Masashi Narazaki, Tadamitsu Kishimoto	2000	65
19	Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin‐6 FEBS Letters ·Xinzhuo Wang, Yin Liu, Masashi Narazaki, Masahiko Hibi, Tadamitsu Kishimoto, Tetsuya Taga	1997	27
20	Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3 Biochemical and Biophysical Research Communications ·Seijiro Minamoto, Kazuhiro Ikegame, Kiyonobu Ueno, Masashi Narazaki, Tetsuji Naka, Hiroyasu Yamamoto, Tomoshige Matsumoto, Hiroshi Saito, Shigeto Hosoe, Tadamitsu Kishimoto	1997	140

About Masashi Narazaki

Masashi Narazaki is a scholar working on Rheumatology, Hematology, Oncology, Immunology and Anatomy, having authored 92 papers that have together received 14.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (29 papers), Autoimmune and Inflammatory Disorders Research (14 papers), Systemic Lupus Erythematosus Research (14 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Immune Cell Function and Interaction (7 papers), Inflammasome and immune disorders (7 papers), Pharmacological Effects of Natural Compounds (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). The work is most often cited by research in Immunology (5.0k citations), Oncology (4.9k citations), Pharmacology (998 citations), Rheumatology (1.4k citations) and Hematology (921 citations). Masashi Narazaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshio Tanaka, Tadamitsu Kishimoto, T Kishimoto, Tetsuya Taga, Shizuo Akira, Tetsuji Naka, Sujin Kang, Tomoshige Matsumoto, Kazuyuki Yoshizaki and Tadahiro Kajita. Their work appears in journals such as Modern Rheumatology, Blood, Proceedings of the National Academy of Sciences, FEBS Letters and International Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact